BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30214568)

  • 1. Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma.
    Liu J; Wang L; Wang T; Wang J
    Oncol Lett; 2018 Oct; 16(4):4325-4330. PubMed ID: 30214568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of serum soluble interleukin-23 receptor and related T-helper 17 cell cytokines in non-small cell lung carcinoma.
    Liu D; Xing S; Wang W; Huang X; Lin H; Chen Y; Lan K; Chen L; Luo F; Qin S; Liang R; Bai C; Xu J; Liu W
    Cancer Sci; 2020 Apr; 111(4):1093-1102. PubMed ID: 32020720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Effect of IL-12Rβ2 and IL-23R Expression on Prognosis of Patients with Laryngeal Cancer.
    Tao Y; Tao T; Gross N; Peng X; Li Y; Huang Z; Liu L; Li G; Chen X; Yang J
    Cell Physiol Biochem; 2018; 50(3):1041-1054. PubMed ID: 30355949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.
    Li M; Cai Y; Zhao H; Xu Z; Sun Q; Luo M; Gu L; Meng M; Han X; Sun H
    Tumour Biol; 2015 Jun; 36(6):4785-92. PubMed ID: 25647262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy-associated HMGB-1 as a novel potential circulating non-invasive diagnostic marker for detection of Urothelial Carcinoma of Bladder.
    Singh A; Gupta N; Khandakar H; Kaushal S; Seth A; Pandey RM; Sharma A
    Mol Cell Biochem; 2022 Feb; 477(2):493-505. PubMed ID: 34796446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients.
    Liu X; Yao D; Liu C; Cao Y; Yang Q; Sun Z; Liu D
    Tumour Biol; 2016 Jun; 37(6):8367-74. PubMed ID: 26733163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
    Huo J; Hu J; Liu G; Cui Y; Ju Y
    Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of expression levels of IL-17 and IL-34 and influencing factors for prognosis in patients with lupus nephritis.
    Cheng Y; Yang X; Zhang X; An Z
    Exp Ther Med; 2019 Mar; 17(3):2279-2283. PubMed ID: 30783486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
    Xiong J; Xiong K; Bing Z
    Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer.
    Lin R; Shen W; Zhi Y; Zhou Z
    Biomed Pharmacother; 2014 Oct; 68(8):929-34. PubMed ID: 25455159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
    Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased interleukin-23 receptor (IL-23R) expression is associated with disease severity in acute-on-chronic liver failure.
    Khanam A; Trehanpati N; Sarin SK
    Liver Int; 2019 Jun; 39(6):1062-1070. PubMed ID: 30506912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBC
    Ecke TH; Weiß S; Stephan C; Hallmann S; Arndt C; Barski D; Otto T; Gerullis H
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of IL-23R gene polymorphism with clinicopathological characteristics and prognosis of hepatocellular carcinoma patients after interventional therapy.
    Pan X; Wang G
    Genomics; 2019 Jul; 111(4):930-935. PubMed ID: 29864461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of mir-143 in serum of bladder cancer patients and its correlation with clinical features and prognosis.
    Liu X; Zhao W; Wang X; Zhu Y; Zhou Z; Shi B
    J BUON; 2019; 24(2):791-796. PubMed ID: 31128037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBC
    Ecke TH; Weiß S; Stephan C; Hallmann S; Barski D; Otto T; Gerullis H
    Tumour Biol; 2017 May; 39(5):1010428317701624. PubMed ID: 28468590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
    Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Expression of IL-23 Receptor (IL-23R) in Vogt-Koyanagi-Harada (VKH) Disease.
    Wang C; Wang L; Hu J; Li H; Kijlstra A; Yang P
    Curr Eye Res; 2018 Nov; 43(11):1369-1373. PubMed ID: 29877734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
    Pan GF; Zhou XF; Zhao JP
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.